These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 31819163)

  • 41. Personalized medicine in psoriasis: concept and applications.
    Al-Hoqail IA
    Curr Vasc Pharmacol; 2010 May; 8(3):432-6. PubMed ID: 19758113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacogenomics: paving the path to personalized medicine.
    Patrinos GP; Innocenti F
    Pharmacogenomics; 2010 Feb; 11(2):141-6. PubMed ID: 20136354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.
    Haidar CE; Crews KR; Hoffman JM; Relling MV; Caudle KE
    Annu Rev Genomics Hum Genet; 2022 Aug; 23():449-473. PubMed ID: 35537468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Editorial: SNPs of drug metabolic enzymes and personalized medicine Part II.
    Wei DQ; Chen Q
    Curr Drug Metab; 2012 Sep; 13(7):951. PubMed ID: 22475268
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What do we need to transfer pharmacogenetics findings into the clinic?
    Slob EMA; Vijverberg SJH; Pijnenburg MW; Koppelman GH; Maitland-van der Zee AH
    Pharmacogenomics; 2018 May; 19(7):589-592. PubMed ID: 29701121
    [No Abstract]   [Full Text] [Related]  

  • 47. Implementation of a multidisciplinary pharmacogenomics clinic in a community health system.
    Dunnenberger HM; Biszewski M; Bell GC; Sereika A; May H; Johnson SG; Hulick PJ; Khandekar J
    Am J Health Syst Pharm; 2016 Dec; 73(23):1956-1966. PubMed ID: 27864203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
    Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
    Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Personalized Medicine and Nonmotor Symptoms in Parkinson's Disease.
    Titova N; Chaudhuri KR
    Int Rev Neurobiol; 2017; 134():1257-1281. PubMed ID: 28805572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implementation of Pharmacogenetics at Cincinnati Children's Hospital Medical Center: Lessons Learned Over 14 Years of Personalizing Medicine.
    Ramsey LB; Prows CA; Zhang K; Saldaña SN; Sorter MT; Pestian JP; Wenstrup RJ; Vinks AA; Glauser TA
    Clin Pharmacol Ther; 2019 Jan; 105(1):49-52. PubMed ID: 30058217
    [No Abstract]   [Full Text] [Related]  

  • 52. Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts.
    Caraballo PJ; Bielinski SJ; St Sauver JL; Weinshilboum RM
    Clin Pharmacol Ther; 2017 Aug; 102(2):254-264. PubMed ID: 28390138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacogenomic biomarkers: validation needed for both the molecular genetic mechanism and clinical effect.
    Sadee W
    Pharmacogenomics; 2011 May; 12(5):675-80. PubMed ID: 21619429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Big data in pharmacogenomics: current applications, perspectives and pitfalls.
    Barrot CC; Woillard JB; Picard N
    Pharmacogenomics; 2019 Jun; 20(8):609-620. PubMed ID: 31190620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tabula Rasa HealthCare company profile: involvement in pharmacogenomic and personalized medicine research.
    Matos A; Dow P; Bingham JM; Michaud V; Lesko LJ; Knowlton CH; Turgeon J
    Pharmacogenomics; 2021 Aug; 22(12):731-735. PubMed ID: 34284600
    [No Abstract]   [Full Text] [Related]  

  • 56. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
    Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
    Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
    Lazaridis KN
    Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacogenetics of heart failure.
    Mestroni L; Begay RL; Graw SL; Taylor MR
    Curr Opin Cardiol; 2014 May; 29(3):227-34. PubMed ID: 24717669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetics and genomics: the scientific drivers of personalized medicine.
    Kurnat-Thoma EL
    Annu Rev Nurs Res; 2011; 29():27-54. PubMed ID: 22891497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Precision medicine: a call for increased pharmacogenomic education.
    Ta R; Cayabyab MA; Coloso R
    Per Med; 2019 May; 16(3):233-245. PubMed ID: 31025601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.